The START-SIAPAV-PAD Registry – Rationale, study design, and baseline characteristics of an ongoing Italian multicentre registry
Summary: Background: Peripheral artery disease (PAD) is associated with a high burden of cardiovascular and limb events, yet guideline-directed medical therapy remains suboptimal. The START-SIAPAV-PAD registry was designed to describe characteristics, management and clinical history of patients with PAD in Italy. Baseline characteristics and treatment are reported. Patients and methods: START-SIAPAV-PAD is a prospective, multicentre, observational registry enrolling consecutive adults with PAD managed at 20 Italian Vascular centres, starting in February 2023. Standardised electronic case-report forms collect demographics, risk factors, comorbidities, haemodynamic parameters, vascular anatomy, therapies. Follow-up is planned for a minimum of 3 years. PAD severity is classified according to the Leriche-Fontaine scale, and risk-factor targets follow the 2024 ESC guidelines. Results: The present analysis includes 517 patients (72.0% male; median age 71 years) with a high prevalence of hypertension (79.2%), dyslipidaemia (85.0%), diabetes (36.9%), smoking (96.1% current or former) and chronic kidney disease (21.2%). Nearly half reported a walking distance <200 m, 77.5% had a resting ankle–brachial index ≤.80, and 17.2% presented with Leriche-Fontaine stage IV. Femoropopliteal disease was most frequent (69.8%), with multilevel involvement in 43.4%. Previous revascularisation was common, major amputation was rare. LDL cholesterol target (<55mg dL) was achieved in 27.9% of patients despite lipid-lowering therapy in 82.1%. Dual pathway inhibition, advanced lipid-lowering therapies, supervised exercise and structured smoking-cessation programmes were insufficiently adopted. Conclusions: In a population with advanced PAD and multiple risk factors we observed a substantial gap between guideline recommendations and real-world practice. Longitudinal follow-up will assess outcomes and opportunities to improve PAD management.
Authors
- Pasquale Pignatelli (ORCID: https://orcid.org/0000-0002-2265-7455)
- Adriana Visonà (ORCID: https://orcid.org/0000-0002-2558-1003)
- Angelo Porfidia (ORCID: https://orcid.org/0000-0003-4915-2892)
- Michela Cini (ORCID: https://orcid.org/0000-0001-9681-6159)
- Luca Puccetti (ORCID: https://orcid.org/0000-0002-4022-8822)
- Beniamino Zalunardo
- Corrado Amato (ORCID: https://orcid.org/0009-0002-9491-5027)
- Anita Carlizza
- Walter Dorigo (ORCID: https://orcid.org/0000-0003-3814-5961)
- Marco Marzolo
- Federico Biscetti (ORCID: https://orcid.org/0000-0001-7449-657X)
- Emilia Antonucci (ORCID: https://orcid.org/0000-0001-9185-2046)
- Elena Lotti
- Francesca Ghirardini
- Walter Ageno (ORCID: https://orcid.org/0000-0002-1922-8879)
- Elisabetta Favaretto (ORCID: https://orcid.org/0000-0002-1811-7798)
Institutions
- University of Siena (IT)
- Università Cattolica del Sacro Cuore (IT)
- University of Padua (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- Agostino Gemelli University Polyclinic (IT)
- University Hospital Foundation (CA)
- AULSS 2 Marca Trevigiana (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
- University of Florence (IT)
- Sapienza University of Rome (IT)
- University of Palermo (IT)
Publication Details
- Journal
- VASA
- Published
- 2026-10-22
- DOI
- https://doi.org/10.1024/0301-1526/a001310
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00